🇺🇸 FDA
Drug

entrectinib

Brand: ROZLYTREK

approved

Quick answer

entrectinib (ROZLYTREK), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
entrectinib
Brand
ROZLYTREK
Route
ORAL
Formulation
CAPSULE

Related news

FDA Approves Roche's NTRK Fusion Therapy for Solid Tumors
NewsOncologyMar 31, 2026

FDA Approves Roche's NTRK Fusion Therapy for Solid Tumors

Roche's NTRK Fusion Therapy receives FDA approval, marking a significant advancement in the treatment of solid tumors with NTRK gene fusions.

Dr. Sarah Mitchell

Frequently asked questions

What is entrectinib?

entrectinib (ROZLYTREK), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for entrectinib?

ROZLYTREK is a marketed brand name for entrectinib. Check FDA Drugs@FDA for the current US label holder.